chr1-12005784-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_014874.4(MFN2):​c.1569C>T​(p.Ser523Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0552 in 1,614,182 control chromosomes in the GnomAD database, including 2,840 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.047 ( 234 hom., cov: 33)
Exomes 𝑓: 0.056 ( 2606 hom. )

Consequence

MFN2
NM_014874.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.654
Variant links:
Genes affected
MFN2 (HGNC:16877): (mitofusin 2) This gene encodes a mitochondrial membrane protein that participates in mitochondrial fusion and contributes to the maintenance and operation of the mitochondrial network. This protein is involved in the regulation of vascular smooth muscle cell proliferation, and it may play a role in the pathophysiology of obesity. Mutations in this gene cause Charcot-Marie-Tooth disease type 2A2, and hereditary motor and sensory neuropathy VI, which are both disorders of the peripheral nervous system. Defects in this gene have also been associated with early-onset stroke. Two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 1-12005784-C-T is Benign according to our data. Variant chr1-12005784-C-T is described in ClinVar as [Benign]. Clinvar id is 138215.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-12005784-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.654 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.118 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MFN2NM_014874.4 linkc.1569C>T p.Ser523Ser synonymous_variant Exon 15 of 19 ENST00000235329.10 NP_055689.1 O95140-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MFN2ENST00000235329.10 linkc.1569C>T p.Ser523Ser synonymous_variant Exon 15 of 19 1 NM_014874.4 ENSP00000235329.5 O95140-1

Frequencies

GnomAD3 genomes
AF:
0.0468
AC:
7128
AN:
152202
Hom.:
233
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0234
Gnomad AMI
AF:
0.0647
Gnomad AMR
AF:
0.0419
Gnomad ASJ
AF:
0.0815
Gnomad EAS
AF:
0.126
Gnomad SAS
AF:
0.0751
Gnomad FIN
AF:
0.0177
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0567
Gnomad OTH
AF:
0.0460
GnomAD2 exomes
AF:
0.0545
AC:
13696
AN:
251496
AF XY:
0.0570
show subpopulations
Gnomad AFR exome
AF:
0.0228
Gnomad AMR exome
AF:
0.0236
Gnomad ASJ exome
AF:
0.0834
Gnomad EAS exome
AF:
0.132
Gnomad FIN exome
AF:
0.0159
Gnomad NFE exome
AF:
0.0545
Gnomad OTH exome
AF:
0.0492
GnomAD4 exome
AF:
0.0561
AC:
82027
AN:
1461862
Hom.:
2606
Cov.:
32
AF XY:
0.0563
AC XY:
40951
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0231
AC:
775
AN:
33480
American (AMR)
AF:
0.0255
AC:
1140
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0795
AC:
2078
AN:
26136
East Asian (EAS)
AF:
0.105
AC:
4175
AN:
39700
South Asian (SAS)
AF:
0.0733
AC:
6319
AN:
86258
European-Finnish (FIN)
AF:
0.0155
AC:
827
AN:
53420
Middle Eastern (MID)
AF:
0.0425
AC:
245
AN:
5766
European-Non Finnish (NFE)
AF:
0.0566
AC:
62910
AN:
1111984
Other (OTH)
AF:
0.0589
AC:
3558
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
4937
9874
14812
19749
24686
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2444
4888
7332
9776
12220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0468
AC:
7133
AN:
152320
Hom.:
234
Cov.:
33
AF XY:
0.0470
AC XY:
3504
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0235
AC:
976
AN:
41576
American (AMR)
AF:
0.0418
AC:
640
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0815
AC:
283
AN:
3472
East Asian (EAS)
AF:
0.126
AC:
655
AN:
5194
South Asian (SAS)
AF:
0.0756
AC:
365
AN:
4828
European-Finnish (FIN)
AF:
0.0177
AC:
188
AN:
10618
Middle Eastern (MID)
AF:
0.0578
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
0.0567
AC:
3855
AN:
68022
Other (OTH)
AF:
0.0450
AC:
95
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
344
687
1031
1374
1718
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0502
Hom.:
102
Bravo
AF:
0.0469
Asia WGS
AF:
0.0910
AC:
317
AN:
3478
EpiCase
AF:
0.0567
EpiControl
AF:
0.0609

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 24, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Charcot-Marie-Tooth disease type 2 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Charcot-Marie-Tooth disease Benign:1
-
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary motor and sensory neuropathy with optic atrophy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
10
DANN
Benign
0.83
PhyloP100
0.65
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs1042837; hg19: chr1-12065841; COSMIC: COSV52422680; API